Micro-UltraSound In Cancer - Active Surveillance
NCT: NCT05558241 · RECRUITING
Brief Summary
This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.
Frequently Asked Questions
What is Micro-UltraSound In Cancer - Active Surveillance?
Micro-UltraSound In Cancer - Active Surveillance is a clinical trial registered under NCT05558241. Current status: RECRUITING.
What is the status of NCT05558241?
The current status of NCT05558241 (Micro-UltraSound In Cancer - Active Surveillance) is: RECRUITING.
When did Micro-UltraSound In Cancer - Active Surveillance start?
Micro-UltraSound In Cancer - Active Surveillance started on 2022-11-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.